参考文献/References:
[1] Itamochi H, Kigawa J.Molecular targeted therapies for epithe-lial ovarian cancer[J]. Nihon Rinsho,2012, 70(S4): 622-627.
[2] Kroeger P J, Drapkin R.Pathogenesis and heterogeneity of ovarian cancer[J]. Curr Opin Obstet Gynecol,2017, 29(1): 26-34.
[3] Squadrito M L, Baer C, Burdet F, et al.Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells[J]. Cell Rep,2014, 8(5): 1432-1446.
[4] Taylor D D, Gercel-Taylor C.MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer[J]. Gynecol Oncol,2008, 110(1): 13-21.
[5] Deng J L, Xu Y H, Wang G.Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis[J]. Front Genet,2019, 10: 695.
[6] Reczko M, Maragkakis M, Alexiou P, et al.Functional microRNA targets in protein coding sequences[J]. Bioinfor-matics,2012, 28(6): 771-776.
[7] Yi H, Ye J, Yang X M, et al.High-grade ovarian cancer secreting effective exosomes in tumor angiogenesis[J]. Int J Clin Exp Pathol,2015, 8(5): 5062-5070.
[8] Yi H, Zheng X, Song J, et al.Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis[J]. Int J Clin Exp Pathol,2015, 8(12): 15719-15728.
[9] Zeng Z, Li Y, Pan Y, et al.Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis[J]. Nat Commun,2018, 9(1): 5395.
[10] Fong M Y, Zhou W, Liu L, et al.Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis[J]. Nat Cell Biol,2015, 17(2): 183-194.
[11] Ippolito L, Marini A, Cavallini L, et al.Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells[J]. Oncotarget,2016, 7(38): 61890-61904.
[12] Wang Z, Wang J, Yang Y, et al.Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer[J]. J Exp Clin Cancer Res,2013, 32: 76.
[13] Guo X, Han T, Hu P, et al.Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention[J]. Int Urol Nephrol,2018, 50(12): 2193-2200.
相似文献/References:
[1]林文韬 王武炼 肖莉莉 张怡元.基于GEO数据库发现骨肉瘤关键基因GMFG及其生物学功能[J].福建医药杂志,2020,42(02):112.
LIN Wentao,WANG Wulian,XIAO Lili,et al.Identification of the key gene GMFG and its biological function in osteosarcoma based on GEO database[J].FUJIAN MEDICAL JOURNAL,2020,42(05):112.
[2]郑金辉,梁玮,林晓露,等.基于数据挖掘分析炭疽毒素受体1在胃癌中的表达及其意义[J].福建医药杂志,2021,43(01):14.
ZHENG Jinhui,LIANG Wei,LIN Xiaolu,et al.Expression of ANTXR1 gene in gastric cancer and its significance based on data mining[J].FUJIAN MEDICAL JOURNAL,2021,43(05):14.
[3]程辉.基于数据挖掘分析G蛋白偶联受体116在弥漫大B细胞淋巴瘤中的表达及功能预测[J].福建医药杂志,2021,43(03):22.
CHENG Hui.Analysis of GPR116 expression and function prediction in diffuse large B cell lymphoma based on data mining[J].FUJIAN MEDICAL JOURNAL,2021,43(05):22.
[4]王雪春,徐榕莉,郑秀琼.妊娠期糖尿病相关差异表达基因的生物信息学分析[J].福建医药杂志,2022,44(02):6.
WANG Xuechun,XV Rongli,ZHENG Xiuqiong.Bioinformation analysis of gestational diabetes mellitus-related differentially expressed genes[J].FUJIAN MEDICAL JOURNAL,2022,44(05):6.
[5]吴嘉旭,胡明超,王强,等.NDC1基因在肝癌中的诊断及预后价值的生物信息学分析[J].福建医药杂志,2023,45(01):7.
WU Jiaxu,HU Mingchao,WANG Qiang,et al.Bioinformatics analysis of the diagnostic and prognostic value of NDC1 gene in liver hepatocellular carcinoma[J].FUJIAN MEDICAL JOURNAL,2023,45(05):7.
[6]沈明虹.上皮性卵巢癌HMGB3表达及预后价值的生物信息学分析[J].福建医药杂志,2023,45(06):1.
SHEN Minghong.Analysis of HMGB3 expression and prognostic value in epithelial ovarian cancer based on bioinformatics[J].FUJIAN MEDICAL JOURNAL,2023,45(05):1.
[7]苏川,齐元麟.M2型丙酮酸激酶在宫颈鳞状细胞癌和宫颈腺癌中临床意义的生物信息学分析[J].福建医药杂志,2024,46(02):1.[doi:10.20148/j.fmj.2024.02.001]
SU Chuan,QI Yuanlin.Bioinformatics analysis of the clinical significance of PKM2 in cervical squamous cell carcinoma and endocervical adenocarcinoma[J].FUJIAN MEDICAL JOURNAL,2024,46(05):1.[doi:10.20148/j.fmj.2024.02.001]